Receiving the award  at the Bangalore Technology Summit, on Friday, November 30,2018, Dr. Sunit Maity , Director-Product Development at Zumutor said “We have raised additional funds this year from our lead investor for ongoing development of our lead immuno oncotherapy molecule to enable IND filing in 2019”.